Reda F M Elshaarawy
Overview
Explore the profile of Reda F M Elshaarawy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alqahtani N, Alfaifi M, Shati A A, Elbehairi S, Saleh A, Kotb E, et al.
RSC Adv
. 2024 Dec;
14(52):39027-39039.
PMID: 39659603
Two new thiadiazole imidazolium salicylidene Schiff bases (TISSBs) were successfully synthesized, and their structures were analyzed comprehensively using spectroscopic techniques. The results of the MTT assay showed that TISSB2 was...
2.
Abd El-Fattah W, Alfaifi M, Alkabli J, Ramadan H, Shati A, Elbehairi S, et al.
Antibiotics (Basel)
. 2024 Sep;
13(9).
PMID: 39335087
In the original publication [...].
3.
Alhamdi H, Alfaifi M, Shati A, Elbehairi S, Er-Rajy M, Elshaarawy R, et al.
RSC Adv
. 2024 Sep;
14(41):29890.
PMID: 39301240
[This corrects the article DOI: 10.1039/D4RA04219K.].
4.
Mahmoud N, Abdel Moneim A, Darweesh O, El Zahaby E, Elshaarawy R, Hassan Y, et al.
RSC Adv
. 2024 Sep;
14(40):29330-29343.
PMID: 39285882
This research explores the potential of encapsulating thyme essential oil (TEO) and thymol (TH) into quaternized chitosan nanocapsules to combat SARS-CoV-2. Initially, the bioactive materials, TH and TEO, were extracted...
5.
Alhamdi H, Alfaifi M, Shati A, Elbehairi S, Er-Rajy M, Elshaarawy R, et al.
RSC Adv
. 2024 Sep;
14(39):28555-28568.
PMID: 39247509
Recently, molecular hybrids of two or more active pharmacophores have shown promise for designing and synthesizing anticancer drugs. Herein, a new multifunctional hybrid (PAHMQ), combining azobenzene and quinoline pharmacophores, and...
6.
Awaji A, Alhamdi H, Alshehri K, Alfaifi M, Shati A, Elbehairi S, et al.
J Inorg Biochem
. 2024 Sep;
262:112720.
PMID: 39243420
This study investigated the effectiveness and safety of a hybrid thiosemicarbazone ligand (HL) and its metal complexes (Mn-L, Fe-L, Ni-HL, and Zn-HL) against epidermoid carcinoma (A-431). The results indicated that...
7.
Yahya R, Elshaarawy R
Int J Biol Macromol
. 2024 Aug;
277(Pt 2):134350.
PMID: 39094877
In this study, a novel and cost-effective approach was employed to prepare an effective Pb(II) adsorbent. We synthesized highly porous CMCSB-SCB microbeads with multiple active binding sites by combining carboxymethylated...
8.
Kotb E, Alhamdi H, Alfaifi M, Darweesh O, Shati A, Elbehairi S, et al.
Int J Biol Macromol
. 2024 Jul;
276(Pt 1):133616.
PMID: 39009258
Background: Despite cisplatin's long history as a cornerstone in cancer therapy, both acquired chemoresistance and significant impacts on healthy tissues limit its use. Hepatotoxicity is one of its side effects....
9.
Rizk M, Yahya R, Alsaiari R, Alsaiari M, Shahat A, Elshaarawy R
Environ Sci Pollut Res Int
. 2024 May;
31(26):38180-38195.
PMID: 38789710
A novel adsorbent (MIL-CMIVSB) was fabricated by modification of HN-MIL-101(Cr) with carboxymethyl-imidazolium O-vanillin Schiff base. The MIL-CMIVSB's physicochemical characteristics were examined using the pertinent characterization methods. NH-MIL-101(Cr) has a BET...
10.
Awaji A, Rizk M, Alsaiari R, Alqahtani N, Al-Qadri F, Alkorbi A, et al.
Pharmaceuticals (Basel)
. 2023 Dec;
16(12).
PMID: 38139837
Two bis-(imidazolium-vanillylidene)-(,)-diaminocyclohexane ligands (H(VAN)dach, HL) and their Pd(II) complexes (PdL and PdL) were successfully synthesized and structurally characterized using microanalytical and spectral methods. Subsequently, to target the development of new...